These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 24166180)

  • 1. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
    Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
    Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between molecular subtypes of colorectal cancer and patient survival.
    Phipps AI; Limburg PJ; Baron JA; Burnett-Hartman AN; Weisenberger DJ; Laird PW; Sinicrope FA; Rosty C; Buchanan DD; Potter JD; Newcomb PA
    Gastroenterology; 2015 Jan; 148(1):77-87.e2. PubMed ID: 25280443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic alterations, metabolizing genes and smoking in rectal cancer.
    Curtin K; Samowitz WS; Wolff RK; Herrick J; Caan BJ; Slattery ML
    Int J Cancer; 2009 Jul; 125(1):158-64. PubMed ID: 19358278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrichment of Bacteroides fragilis and enterotoxigenic Bacteroides fragilis in CpG island methylator phenotype-high colorectal carcinoma.
    Takashima Y; Kawamura H; Okadome K; Ugai S; Haruki K; Arima K; Mima K; Akimoto N; Nowak JA; Giannakis M; Garrett WS; Sears CL; Song M; Ugai T; Ogino S
    Clin Microbiol Infect; 2024 May; 30(5):630-636. PubMed ID: 38266708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis.
    Lannagan TRM; Lee YK; Wang T; Roper J; Bettington ML; Fennell L; Vrbanac L; Jonavicius L; Somashekar R; Gieniec K; Yang M; Ng JQ; Suzuki N; Ichinose M; Wright JA; Kobayashi H; Putoczki TL; Hayakawa Y; Leedham SJ; Abud HE; Yilmaz ÖH; Marker J; Klebe S; Wirapati P; Mukherjee S; Tejpar S; Leggett BA; Whitehall VLJ; Worthley DL; Woods SL
    Gut; 2019 Apr; 68(4):684-692. PubMed ID: 29666172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma.
    Stefanius K; Ylitalo L; Tuomisto A; Kuivila R; Kantola T; Sirniö P; Karttunen TJ; Mäkinen MJ
    Histopathology; 2011 Apr; 58(5):679-92. PubMed ID: 21457162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMO expression in colorectal cancer: associations with clinical, pathological, and molecular features.
    Li T; Liao X; Lochhead P; Morikawa T; Yamauchi M; Nishihara R; Inamura K; Kim SA; Mima K; Sukawa Y; Kuchiba A; Imamura Y; Baba Y; Shima K; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S; Qian ZR
    Ann Surg Oncol; 2014 Dec; 21(13):4164-73. PubMed ID: 25023548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body size and risk of colorectal cancer molecular defined subtypes and pathways: Mendelian randomization analyses.
    Papadimitriou N; Qu C; Harrison TA; Bever AM; Martin RM; Tsilidis KK; Newcomb PA; Thibodeau SN; Newton CC; Um CY; Obón-Santacana M; Moreno V; Brenner H; Mandic M; Chang-Claude J; Hoffmeister M; Pellatt AJ; Schoen RE; Harlid S; Ogino S; Ugai T; Buchanan DD; Lynch BM; Gruber SB; Cao Y; Hsu L; Huyghe JR; Lin Y; Steinfelder RS; Sun W; Van Guelpen B; Zaidi SH; Toland AE; Berndt SI; Huang WY; Aglago EK; Drew DA; French AJ; Georgeson P; Giannakis M; Hullar M; Nowak JA; Thomas CE; Le Marchand L; Cheng I; Gallinger S; Jenkins MA; Gunter MJ; Campbell PT; Peters U; Song M; Phipps AI; Murphy N
    EBioMedicine; 2024 Mar; 101():105010. PubMed ID: 38350331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of SATB2 and CDX2 expression is associated with DNA mismatch repair protein deficiency and BRAF mutation in colorectal cancer.
    Li J; Zeng Q; Lin J; Huang H; Chen L
    Med Mol Morphol; 2024 Mar; 57(1):1-10. PubMed ID: 37583001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mismatch Repair (MMR) Gene Alteration and BRAF V600E Mutation Are Potential Predictive Biomarkers of Immune Checkpoint Inhibitors in MMR-Deficient Colorectal Cancer.
    Sahin IH; Goyal S; Pumpalova Y; Sonbol MB; Das S; Haraldsdottir S; Ahn D; Ciombor KK; Chen Z; Draper A; Berlin J; Bekaii-Saab T; Lesinski GB; El-Rayes BF; Wu C
    Oncologist; 2021 Aug; 26(8):668-675. PubMed ID: 33631043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication.
    Lochhead P; Kuchiba A; Imamura Y; Liao X; Yamauchi M; Nishihara R; Qian ZR; Morikawa T; Shen J; Meyerhardt JA; Fuchs CS; Ogino S
    J Natl Cancer Inst; 2013 Aug; 105(15):1151-6. PubMed ID: 23878352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional loss of MSH2 and MSH6 expression in sporadic deficient mismatch repair colorectal cancer due to MLH1 promoter hypermethylation.
    Westwood A; Glover A; Hutchins G; Young C; Brockmoeller S; Robinson R; Worrilow L; Wallace D; Rankeillor K; Adlard J; Quirke P; West N
    J Clin Pathol; 2019 Jun; 72(6):443-447. PubMed ID: 30723092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques.
    Deycmar S; Johnson BJ; Ray K; Schaaf GW; Ryan DP; Cullin C; Dozier BL; Ferguson B; Bimber BN; Olson JD; Caudell DL; Whitlow CT; Solingapuram Sai KK; Romero EC; Villinger FJ; Burgos AG; Ainsworth HC; Miller LD; Hawkins GA; Chou JW; Gomes B; Hettich M; Ceppi M; Charo J; Cline JM
    J Transl Med; 2024 Mar; 22(1):292. PubMed ID: 38504345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancer.
    Schafroth C; Galván JA; Centeno I; Koelzer VH; Dawson HE; Sokol L; Rieger G; Berger MD; Hädrich M; Rosenberg R; Nitsche U; Schnüriger B; Langer R; Inderbitzin D; Lugli A; Zlobec I
    Oncotarget; 2015 Dec; 6(39):41453-63. PubMed ID: 26496026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Smoking and Molecular Subtypes of Colorectal Cancer.
    Wang X; Amitay E; Harrison TA; Banbury BL; Berndt SI; Brenner H; Buchanan DD; Campbell PT; Cao Y; Chan AT; Chang-Claude J; Gallinger SJ; Giannakis M; Giles GG; Gunter MJ; Hopper JL; Jenkins MA; Lin Y; Moreno V; Nishihara R; Newcomb PA; Ogino S; Phipps AI; Sakoda LC; Schoen RE; Slattery ML; Song M; Sun W; Thibodeau SN; Toland AE; Van Guelpen B; Woods MO; Hsu L; Hoffmeister M; Peters U
    JNCI Cancer Spectr; 2021 Aug; 5(4):. PubMed ID: 34377935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Characteristics of Early-Onset Colorectal Cancer According to Detailed Anatomical Locations: Comparison With Later-Onset Cases.
    Ugai T; Haruki K; Harrison TA; Cao Y; Qu C; Chan AT; Campbell PT; Akimoto N; Berndt S; Brenner H; Buchanan DD; Chang-Claude J; Fujiyoshi K; Gallinger SJ; Gunter MJ; Hidaka A; Hoffmeister M; Hsu L; Jenkins MA; Milne RL; Moreno V; Newcomb PA; Nishihara R; Pai RK; Sakoda LC; Slattery ML; Sun W; Amitay EL; Alwers E; Thibodeau SN; Toland AE; Van Guelpen B; Woods MO; Zaidi SH; Potter JD; Giannakis M; Song M; Nowak JA; Phipps AI; Peters U; Ogino S
    Am J Gastroenterol; 2023 Apr; 118(4):712-726. PubMed ID: 36707929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological features and prognosis of sporadic mismatch repair deficient colorectal cancer].
    Wang H; Hong RP; Chen JC; Wang J; Zhang ZJ; Ren XY; Wu HW; Liang ZY
    Zhonghua Bing Li Xue Za Zhi; 2024 Jul; 53(7):702-708. PubMed ID: 38955702
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies.
    Alvi MA; Loughrey MB; Dunne P; McQuaid S; Turkington R; Fuchs MA; McGready C; Bingham V; Pang B; Moore W; Maxwell P; Lawler M; James JA; Murray GI; Wilson RH; Salto-Tellez M
    Br J Cancer; 2017 Jul; 117(2):203-209. PubMed ID: 28595259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification.
    Nishihara R; Morikawa T; Kuchiba A; Lochhead P; Yamauchi M; Liao X; Imamura Y; Nosho K; Shima K; Kawachi I; Qian ZR; Fuchs CS; Chan AT; Giovannucci E; Ogino S
    Am J Epidemiol; 2013 Jul; 178(1):84-100. PubMed ID: 23788674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history.
    Weisenberger DJ; Levine AJ; Long TI; Buchanan DD; Walters R; Clendenning M; Rosty C; Joshi AD; Stern MC; LeMarchand L; Lindor NM; Daftary D; Gallinger S; Selander T; Bapat B; Newcomb PA; Campbell PT; Casey G; Ahnen DJ; Baron JA; Haile RW; Hopper JL; Young JP; Laird PW; Siegmund KD;
    Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):512-519. PubMed ID: 25587051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.